Tenapanor
| CAS No. | 1234423-95-0 | Cat. No. | BCP24892 |
| Name | Tenapanor | ||
| Synonyms | AZD-1722; AZD 1722; AZD1722; RDX 5791; RDX-5791; RDX5791; | ||
| Formula | C50H66Cl4N8O10S2 | M. Wt | 1145.04 |
| Description | Tenapanor, also known as AZD-1722 and RDX 5791, is an inhibitor of the sodium-proton (Na(+)/H(+)) exchanger NHE3, which plays a prominent role in sodium handling in the gastrointestinal tract and kidney. Tenapanor possesses an excellent preclinical safety profile and, as of now, there are no serious concerns about its side effects. Tenapanor is currently in clinical trials. | ||
| Pathways | Ion Channel/Membrane Transporter | ||
| Targets | Sodium Channel | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.